Monopar Therapeutics Inc. buy BiotechBee
Start price
08.06.24
/
50%
€0.71
Target price
31.01.26
€1.00
Performance (%)
-37.59%
End price
14.12.24
-
Summary
This prediction is currently being closed. The BUY prediction by BiotechBee for Monopar Therapeutics Inc. is performing very badly with a performance of -37.59%. BiotechBee has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Monopar Therapeutics Inc. | - | - | - |
| iShares Core DAX® | 0.444% | 3.030% | 12.677% |
| iShares Nasdaq 100 | 3.819% | 4.073% | 33.152% |
| iShares Nikkei 225® | 1.148% | 6.904% | 45.488% |
| iShares S&P 500 | 2.371% | 2.677% | 25.689% |
According to BiotechBee what are the pros and cons of Monopar Therapeutics Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year